Catherine Pickering PhD, MBA is the CEO and co-founder of iOnctura SA a clinical stage oncology company with a pipeline of programs targeting the tumor-stroma-immune interface. During her career she has held various licensing and business development positions in pharma and biotech including VP, Global Head of Oncology and Immuno-Oncology Licensing and Business Development at Merck.
